Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

870 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Lymphoma cell-of-origin assignment by gene expression profiling is clinically meaningful across broad laboratory contexts.
Gifford G, Gabrielli S, Gill A, Greenwood M, Wong K, Best G, Nevell D, McIlroy K, Kliman D, Ilmay-Gillespie L, Tiley C, Miranda S, Armytage T, Stevenson W. Gifford G, et al. Among authors: greenwood m. Br J Haematol. 2018 Apr;181(2):272-275. doi: 10.1111/bjh.14556. Epub 2017 Feb 15. Br J Haematol. 2018. PMID: 28198001 Free article. No abstract available.
All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4).
Iland HJ, Bradstock K, Supple SG, Catalano A, Collins M, Hertzberg M, Browett P, Grigg A, Firkin F, Hugman A, Reynolds J, Di Iulio J, Tiley C, Taylor K, Filshie R, Seldon M, Taper J, Szer J, Moore J, Bashford J, Seymour JF; Australasian Leukaemia and Lymphoma Group. Iland HJ, et al. Blood. 2012 Aug 23;120(8):1570-80; quiz 1752. doi: 10.1182/blood-2012-02-410746. Epub 2012 Jun 19. Blood. 2012. PMID: 22715121 Free article. Clinical Trial.
Addition of low dose total body irradiation to fludarabine melphalan reduced intensity conditioning is feasible, tolerable, and may improve outcomes in patients with high-risk acute myeloid leukaemia and other high risk myeloid malignancies.
Gifford G, Wong K, Kerridge I, Stevenson W, Arthur C, Fay K, Greenwood M. Gifford G, et al. Among authors: greenwood m. Am J Hematol. 2015 May;90(5):E97-100. doi: 10.1002/ajh.23974. Epub 2015 Mar 2. Am J Hematol. 2015. PMID: 25683457 Free article. No abstract available.
A survey of fertility and sexual health following allogeneic haematopoietic stem cell transplantation in New South Wales, Australia.
Dyer G, Gilroy N, Bradford J, Brice L, Kabir M, Greenwood M, Larsen SR, Moore J, Hertzberg M, Kwan J, Brown L, Hogg M, Huang G, Tan J, Ward C, Kerridge I. Dyer G, et al. Among authors: greenwood m. Br J Haematol. 2016 Feb;172(4):592-601. doi: 10.1111/bjh.13872. Epub 2015 Dec 21. Br J Haematol. 2016. PMID: 26847746 Free article.
Acute myeloid leukaemia relapsing after allogeneic haemopoietic stem cell transplantation: prognostic factors and impact of initial therapy of relapse.
Lim ABM, Curley C, Fong CY, Bilmon I, Beligaswatte A, Purtill D, Getta B, Johnston AM, Armytage T, Collins M, Mason K, Fielding K, Greenwood M, Gibson J, Hertzberg M, Wright M, Lewis I, Moore J, Curtis D, Szer J, Kennedy G, Ritchie D. Lim ABM, et al. Among authors: greenwood m. Intern Med J. 2018 Mar;48(3):276-285. doi: 10.1111/imj.13522. Intern Med J. 2018. PMID: 28628276
870 results